Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHKA | P35790 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | INMT | O95050 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9082734 | 0.98 | USP2 (0.34) | CHKAALDH1A1TSHRKDM4EMAPT | |
| SCHEMBL3352088 | 0.95 | — | — | |
| SCHEMBL6050860 | 0.69 | — | — | |
| SCHEMBL5503657 | 0.67 | — | — | |
| SCHEMBL14941610 | 0.60 | HPGD (0.38) | CHKAALDH1A1TSHRKDM4EMAPT | |
| SCHEMBL14420557 | 0.56 | — | — | |
| SCHEMBL4910246 | 0.56 | — | — | |
| SCHEMBL7961010 | 0.56 | HPGD (0.34) | CHKAALDH1A1TSHRKDM4EMAPT | |
| SCHEMBL497532 | 0.55 | MAPT (0.38) | CHKAALDH1A1MAPTHPGDLMNA | |
| SCHEMBL1157246 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116253642-B | Cannabidiol prodrug, and pharmaceutical composition and application thereof | 山东绿叶制药有限公司 | 2024-07-09 | — | — | CN | disclosed |
| WO-2024003906-A1 | CANNABINOID DERIVATIVES AND COMPOSITIONS COMPRISING SAME | CANNASOUL ANALYTICS LTD. (IL) | 2024-01-04 | — | — | WO | disclosed |
| US-20230372915-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-11-23 | — | — | US | disclosed |
| EP-3188832-B1 | RUTHENIUM COMPLEXES AND THEIR USES AS CATALYSTS IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND RELATED REACTIONS | YEDA RES & DEV (IL) | 2023-10-04 | — | — | EP | disclosed |
| US-11731116-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-08-22 | — | — | US | disclosed |
| CN-116264834-A | Use of hydroxy purines for the treatment of skin disorders | 广东众生睿创生物科技有限公司 | 2023-06-16 | — | — | CN | disclosed |
| CN-116253642-A | Cannabidiol prodrug, and pharmaceutical composition and application thereof | 山东绿叶制药有限公司 | 2023-06-13 | — | — | CN | disclosed |
| WO-2023084516-A1 | NOVEL CANNABINOID DERIVATIVES | CANNASOUL ANALYTICS LTD. (IL) | 2023-05-19 | — | — | WO | disclosed |
| US-20230139910-A1 | COMPOSITIONS AND METHODS FOR TREATING MALARIA | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2023-05-04 | — | — | US | disclosed |
| WO-2023062633-A1 | PROCESS FOR THE PREPARATION OF A SALBUTAMOL INTERMEDIATE | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-04-20 | — | — | WO | disclosed |
| WO-2007133705-A2 | SILOLE-BASED POLYMERS AND SEMICONDUCTOR MATERIALS PREPARED FROM THE SAME | NORTHWESTERN UNIVERSITY (US) | 2007-11-22 | — | — | WO | disclosed |
| WO-2007066336-A2 | CHEMICAL DERIVATIVES OF JASMONATE, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2007-06-14 | — | — | WO | disclosed |
| WO-2007066337-A2 | JASMONATE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | SEPAL PHARMA LTD. (IL) | 2007-06-14 | — | — | WO | disclosed |
| EP-1794145-A1 | PYRAZOLE COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION | Biolipox AB (SE) | 2007-06-13 | — | — | EP | disclosed |
| WO-2006090377-A1 | ONE-POT NON-SYMMETRIC HETEROBIFUNCTIONAL COUPLING OF ORGANIC MOLECULES THROUGH MALONIC ACID DERIVATIVES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-08-31 | — | — | WO | disclosed |
| US-20060148850-A1 | 4-{'3-(Sulfonylamino) phenyl!'1-(cyclymethyl) piperidin-4-ylidene! methyl}benazmide derivativess as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder | ASTRAZENECA AB (SE) | 2006-07-06 | — | — | US | disclosed |
| WO-2006032851-A1 | PYRAZOLE COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION | BIOLIPOX AB (SE) | 2006-03-30 | — | — | WO | disclosed |
| WO-2005007634-A1 | 3-HYDROXY-4-OXO-1,2,3-TRIAZINES AND DERIVATIVES THEREOF FOR AMIDE AND ESTER BOND FORMATION | FRUTAROM LTD. (IL) | 2005-01-27 | — | — | WO | disclosed |
| US-20040039200-A1 | Pirazino(AZA)indole derivatives | VERNALIS RESEARCH LIMITED | 2004-02-26 | — | — | US | disclosed |
| WO-1996040753-A1 | PIPECOLIC ACID DERIVATIVES OF PROLINE THREONINE AMIDES USEFUL FOR THE TREATMENT OF RHEUMATOID ARTHRITIS | G.D. SEARLE & CO. (US) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060148850-A1 | 4-{'3-(Sulfonylamino) phenyl!'1-(cyclymethyl) piperidin-4-ylidene! methyl}benazmide derivativess as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder | OPRD1, OPRK1, OPRM1 | CHKA 2231/4885ALDH1A1 684/4885TSHR 339/4885 |
| US-20230372915-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | ADH1C, OTC, MLEC | CHKA 1342/4885ALDH1A1 1959/4885TSHR 2757/4885 |
| US-20040039200-A1 | Pirazino(AZA)indole derivatives | PIR, GPR119, INMT | CHKA 3248/4885ALDH1A1 452/4885TSHR 440/4885 |
| US-20230139910-A1 | COMPOSITIONS AND METHODS FOR TREATING MALARIA | G6PD, QDPR, FASN | CHKA 216/4885ALDH1A1 1569/4885TSHR 2400/4885 |
| US-11731116-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | ADH1C, OTC, ADH5 | CHKA 1173/4885ALDH1A1 2176/4885TSHR 2543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.